künstliche intelligenz

Did you know that Parkinson’s disease is the fastest-growing brain disease? At the same time, Parkinson’s disease is so variable, almost no 2 individuals’ symptoms and progression are the same. That is why at mediri, we are working every day to improve the diagnosis and therapy of Parkinson’s disease using advanced MR Imaging and Focused Ultrasound techniques.

For more details, you can have a look at this publication on automatic planning of MR-guided transcranial focused ultrasound treatment or this review article on blood-brain barrier dysfunction imaging.

We cordially invite you to join the next ASL Network Dinner which will take place as usually in conjunction with ISMRM – this time in Singapore. mediri and Gold Standard Phantoms are looking forward to be your host on the evening of Sunday, May 5^th in the Neon Pidgeon.

Meet leading experts as well as interested newbies in the research field of Arterial Spin Labelling and enjoy free drinks and food. See you there!
Don’t forget to register here.

We proudly announce that mediri has once again received the Digital Innovator 2024 award from CHIP in the category ”medical technology“.
In times of digitization, CHIP and data analysis specialist Globis Consulting have studied the innovative power of German companies and institutes in digitization. CHIP is known as one of the top recommended brands. See the full ranking here.

Recently, a newspaper article about our project BOSOMSHIELD got mentioned in the newspaper echo-online. If you want to know more about the importance of our work and how we want to improve the field of breast cancer, you can read the article down below. 

Today is International Day of Radiology to promote the seismic impact of radiology on medicine – earlier detection, fewer surgeries, and game-changing treatment outcomes. Analyzing radiological images in multi centric clinical studies can be challenging considering standardization and patient data privacy.
Mediri is constantly evolving its image data management platform mTRIAL for secure and reliable central reads in clinical studies. Currently, mTRIAL is getting ready for RANO 2.0 evaluation of low- and high-grade gliomas according to the recently published update by Wen et al. Stay posted.

RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults | Journal of Clinical Oncology (ascopubs.org)

New office. New Neighbours. New view.
It’s done! We have offically moved to Am Taubenfeld 21/1 in 69123 Heidelberg.

Klinische Forschung neu denken: Vom Patienten bis zur KI.

Ein Aortenaneurysma oder gar eine Aortendissektion wird oft als Nebenbefund auf abdominellen CT-Aufnahmen entdeckt. Im Zweifel muss der Patient aber möglichst schnell weiterbehandelt werden. Wir entwickeln eine automatische, KI-gestützte Auswertung aller abdominellen CT-Aufnahmen in der Cloud, die im Fall eines kritischen Befundes den diensthabenden Arzt direkt alarmiert, so dass der Patient priorisiert werden kann.

Thank you for having us at the BosomShield kick off meeting. BosomShield is a project aiming a computer-aided design system for breast cancer classification and prognosis of relapse.
If you want to know further information about this project, visit bosomshield.eu.

After a successful member audit we are excited to be a part of the Bundesverband Medizinischer Auftragsinstitute e.V. (BVMA). We are looking forward to our first general meeting in Cologne and the networking opportunities.
Want to know more about BVMA? Click here: https://www.bvma.de/